2026 Animal Health Summit Focuses on Workflow Automation, Access, and Longevity

KANSAS CITY, Mo. — More than 675 global animal health executives, investors, and industry entrepreneurs gathered in Kansas City for the 2026 Animal Health Summit to address critical strategic shifts facing the sector. Industry leaders noted that future growth will depend on three main priorities: simplifying veterinary care delivery, expanding therapeutic access, and extending the healthy lifespan of animals.

1. Innovation Focused on Workload Reduction

As veterinary clinics and livestock producers deal with persistent labor shortages and an expanding suite of diagnostic technologies, executive discussions highlighted a shift in how innovation is evaluated.

• Reducing Clinical Burden: New software, diagnostic platforms, and therapeutic formulations are increasingly designed to streamline practice workflows and automate administrative tasks.

• Formulation & Delivery Innovation: Panelists emphasized that major commercial growth will stem not only from novel drug classes, but also from improved formulations, combination therapies, and simplified drug delivery methods that reduce administration time.

2. Expanding Access & Affordability

Presenters emphasized that scientific breakthroughs lose commercial and clinical impact if cost or supply chain barriers prevent widespread adoption across both companion and food animal markets.

Panelists called for alternative care delivery models, broader distribution networks, and targeted pricing structures to reach underserved demographics and livestock operations.

3. The Pivot Toward Pet Longevity and Chronic Disease

A central theme of the summit was the market shift toward pet longevity and preventative care. As pets live longer, venture capital and corporate R&D investments are shifting from acute treatments toward chronic disease management.

• Target Investment Areas: Oncology, chronic kidney disease (CKD), and metabolic conditions were identified as primary drivers for future dealmaking and drug development.

• Diagnostics & Early Intervention: Panelists noted that early diagnostic biomarkers directly increase the lifetime value of patients by enabling earlier therapeutic intervention.

• Consumer Demand: Market research presented at the event indicated that functional health claims related to kidney, cardiac, and longevity support rank among the highest priorities for pet owners in nutritional products.

4. Building Consumer Trust in the “Trust Economy”

Industry analysts highlighted that pet care is increasingly operating within a complex “trust economy”. While pet owners have access to vast amounts of online information, they often struggle to evaluate competing scientific claims.

Panelists concluded that companies introducing novel technologies—including AI-driven diagnostics and digital platforms—must pair innovation with clear communication and strong veterinary relationships to gain long-term adoption.